Use of genomic instruments to reclassify cryptogenic stroke and their potential to guide therapy

被引：0
|
作者：
McCaig, K. [1 ]
Bonney, W. [1 ]
Appleby, P. [1 ]
Donney, A. [1 ]
机构：
[1] Univ Dundee, Farr Inst, Dundee, Scotland
来源：
INTERNATIONAL JOURNAL OF STROKE | 2015年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [31] Retraction Note: Genomic signatures to guide the use of chemotherapeutics
    Anil Potti
    Holly K Dressman
    Andrea Bild
    Richard F Riedel
    Gina Chan
    Robyn Sayer
    Janiel Cragun
    Hope Cottrill
    Michael J Kelley
    Rebecca Petersen
    David Harpole
    Jeffrey Marks
    Andrew Berchuck
    Geoffrey S Ginsburg
    Phillip Febbo
    Johnathan Lancaster
    Joseph R Nevins
    Nature Medicine, 2011, 17 (1) : 135 - 135
  • [32] Analysis of the potential mechanisms of cryptogenic stroke. A hospital-based study of the etiological subtypes of ischemic stroke
    Tsakadze, N.
    Moore, K.
    Ziegler, C.
    Remmel, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 79 - 79
  • [33] Correction: Corrigenda: Genomic signatures to guide the use of chemotherapeutics
    Anil Potti
    Holly K Dressman
    Andrea Bild
    Richard F Riedel
    Gina Chan
    Robyn Sayer
    Janiel Cragun
    Hope Cottrill
    Michael J Kelley
    Rebecca Petersen
    David Harpole
    Jeffrey Marks
    Andrew Berchuck
    Geoffrey S Ginsburg
    Phillip Febbo
    Johnathan Lancaster
    Joseph R Nevins
    Nature Medicine, 2007, 13 (11) : 1388 - 1388
  • [34] Correction: Corrigendum: Genomic signatures to guide the use of chemotherapeutics
    Anil Potti
    Holly K Dressman
    Andrea Bild
    Richard F Riedel
    Gina Chan
    Robyn Sayer
    Janiel Cragun
    Hope Cottrill
    Michael J Kelley
    Rebecca Petersen
    David Harpole
    Jeffrey Marks
    Andrew Berchuck
    Geoffrey S Ginsburg
    Phillip Febbo
    Johnathan Lancaster
    Joseph R Nevins
    Nature Medicine, 2008, 14 (8) : 889 - 889
  • [35] Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke
    Yong, Jean Hai Ein
    Thavorn, Kednapa
    Hoch, Jeffrey S.
    Mamdani, Muhammad
    Thorpe, Kevin E.
    Dorian, Paul
    Sharma, Mike
    Laupacis, Andreas
    Gladstone, David J.
    STROKE, 2016, 47 (09) : 2380 - 2385
  • [36] ASPIRIN USE IN STROKE THERAPY
    YATSU, FM
    WESTERN JOURNAL OF MEDICINE, 1982, 137 (04): : 312 - 313
  • [37] ASPIRIN USE IN STROKE THERAPY
    YATSU, FM
    CONNECTICUT MEDICINE, 1983, 47 (03) : 151 - 151
  • [38] Patent Foramen Ovale Closure Versus Medical Therapy After Cryptogenic Stroke Reply
    Vaduganathan, Muthiah
    Qamar, Arman
    Gupta, Ankur
    Bajaj, Navkaranbir
    Golwala, Harsh B.
    Pandey, Ambarish
    Bhatt, Deepak L.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (06): : E267 - E268
  • [39] Surgical vs. drug therapy in patients with patent foramen ovale and cryptogenic stroke
    Liu, Yunbing
    Wu, Yi
    Xiong, Lu
    HERZ, 2021, 46 (03) : 250 - 254
  • [40] Review: In cryptogenic stroke with PFO, adding PFO closure to medical therapy reduces recurrence
    Syed, Nabeel M.
    Oczkowski, Wieslaw
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (08) : JC43 - JC43
12345